Search results for: 'transform 2014'
- Did you mean
- transform 2024
- transform 2030
- Related search terms
- 2014 china server operating system industry market research report
- 2014 us editing power service market
- 2014 us power distribution service market
- 2014 us editing plan service market
- 2014 us editing part service market
-
24 Feb 2026  |  Global  |  Technology Research
Advanced Solutions for Authentication of eCommerce Returns
Leveraging Intelligent Technologies to Prevent Fraud and Streamline Reverse Logistics in eCommerce Returns
The rapid growth of eCommerce has transformed global retail, driving unprecedented sales volumes while exacerbating challenges such as return fraud, which erodes profits and operational efficiency. This report explores the imperative for new disruptive technologies to authenticate returns and mitigate fraud, thereby safeguarding revenue streams. T...
$4,950.00 -
02 Feb 2021  |  Global  |  Megatrends
Future of Connected Living
The Top 3 Connectivity Ecosystems that will Simplify Human Lives—Homes, Cities, and Workplaces
With more than 20 connected devices per human by 2030, we are rapidly moving to an environment that is permanently online and always connected. An increasingly digitalized and connected world will have a profound impact on a wide range of applications at home, at work, across cities, and several other use-cases (healthcare and automotive, for examp...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Jul 2020  |  North America  |  Market Research
Post-pandemic Global Healthcare Market Outlook, 2020
Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’
Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  North America  |  Market Research
Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities
In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2020  |  Asia Pacific  |  Market Research
Remote Work Requirements Push the Growth Trajectory for Enterprise Videoconferencing Endpoints and Infrastructure in APAC, 2019–2026
Videoconferencing Solutions that Enhance End-user Experience will Help Vendors Rise Above the Competitive Intensity of this Mature Market
This research study analyzes the current and future trends of the Asia-Pacific enterprise videoconferencing endpoints and infrastructure market, service providers' performance, and market share. Despite difficult economic conditions, growing enterprise requirements create opportunities in the Asia-Pacific. The forecast period for this research serv...
$15,000.00
Special Price $11,250.00 save 25 %
-
09 Dec 2020  |  Latin America  |  Market Research
Growth Opportunities for Communications, Collaboration and Customer Care Tools in Healthcare
Enabling Key Healthcare Workflows with Pre-packaged and Programmable Communications Solutions to Enhance Patient and Physician Journeys
Frost & Sullivan has identified the healthcare vertical as ripe for digital transformation and adoption of modern communications and collaboration technologies with the objective of improving operational efficiencies and enhancing patient care. The study covers key use cases for point solutions such as video conferencing or team messaging, as well ...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Nov 2021  |  Asia Pacific  |  Market Research
APAC 5G Network Slicing Growth Opportunities
Strategic Partnerships and the Necessary Investment in 5G Network Slicing will Drive 5G Enterprise Segment Growth
In Asia-Pacific (APAC), 5G network slicing is still at an early stage because of limited 5G commercial launches. The standards for 5G end-to-end network slicing have only recently been completed in June 2021 and have been a bottleneck for the more promising use cases. The majority of mobile operators are planning to implement 5G network slicing by ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Jul 2019  |  Global  |  Megatrends
Data Monetization, Forecast 2018–2022
Powering Innovation Through Data Monetization
An increasing number of companies are starting to build data-driven strategies to fuel growth in the upcoming data economy. Though in its nascent stages, data monetization is having a huge effect on many industry verticals. Every company will, at some stage, transform into a data company through direct or indirect approaches. However, there is a la...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Aug 2019  |  North America  |  Market Research
Contact Center Buyers Guide, North America, 2019
Providers Look to Harness AI to Infuse Intelligence in the Customer Experience
New analysis from Frost & Sullivan's Digital Transformation program finds that growth continues in all areas of the contact center market: premise-based systems, the cloud, and hybrid configurations. Analytics, quality monitoring, and recording continue to be bright spots for growth, but emerging areas are taking center stage as companies transitio...
$3,000.00
Special Price $2,250.00 save 25 %
-
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00
Special Price $3,712.50 save 25 %